A survey of Once-Daily dosage tobramycin therapy in patients with cystic fibrosis

Pediatric Pulmonology

Volumn 44, Issue 4, 2009, Pages 325-329

  Van Meter, Daniel J ^a   Corriveau, Michele ^a,b   Ahern, John W ^a,b   Lahiri, Thomas ^a,b  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Chronic disease; Drug therapy; Health care survey; Lung diseases; Pediatrics

Indexed keywords

CREATININE; TOBRAMYCIN;

ARTICLE; AUDIOMETRY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; E-MAIL; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG UTILIZATION; HEALTH CARE SURVEYS; HOSPITALS; HUMANS; PEDIATRICS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TOBRAMYCIN; UNITED STATES;

EID: 66149157735     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20985     Document Type: Article

References (15)

1. Lahiri T. Approaches to the treatment of initial pseudomonas aeruginosa infection in children who have cystic fibrosis. Clin Chest Med 2007;28:307-318. (Pubitemid 46654476)
2. Smyth AR, Tan KH. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis (review). Cochrane Database of Syst Rev 2006;19:CD002009.
3. Chuck S, Raber S, Rodvold K, Areff D. National survey of extended-interval aminoglycoside dosing. Clin Infect Dis 2000; 30:433-439. (Pubitemid 30205284)
4. Dew RB, Susla GM. Once-daily aminoglycoside treatment. Infect Dis Clin Pract 1996;5:12-24. (Pubitemid 26069832)
5. Aminimanizani A, Beringer PM, Kang J, Tsang L, Jelliffe RW, Shapiro BJ. Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis. J Antimicrob Chemother 2002;50:553-559. (Pubitemid 35214796)
6. Smyth AR, Tan KH, Hyman-Taylor P, Mulheran M, Lewis S, Stableforth D. Knox A for the TOPIC Study Group. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis-the TOPIC study: a randomised controlled trial. Lancet 2005;365:573-578. (Pubitemid 40247913)
7. Coulthard KP, Peckham DG, Conway SP, Smith CA, Bell J, Turnidge J. Therapeutic drug monitoring of once daily tobramy- cin in cystic fibrosis-caution with trough concentrations. J Cyst Fibros 2007;6:125-130. (Pubitemid 46381653)
8. Lam W, Tjon J, Seto W, Dekker A, Wong C, Atenafu E, Bitnun A, Waters V, Yau Y, Solomon M, et al. Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients. J Antimicrob Chemother 2007;59:1135-1140.
9. Massie J, Cranswick N. Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis. J Paediatr Child Health 2006;42:601-605. (Pubitemid 44341888)
10. U.S., Census Bureau, 2000; Census 2000 Geographic Definitions [Online]. Available: http://www.census.gov/geo/www/geo-defn. html#US [Accessed on December 13, 2007].
11. Vic P, Ategbo S, Turck D, Husson MO, Launay V, Loeuille GA, Sardet A, Deschildre A, Druon D, Arrouet-Lagande C. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis. Arch Dis Child 1998;78:536-539. (Pubitemid 28274695)
12. Tan KH, Mulheran M, Knox AJ, Smyth AR. Aminoglycoside prescribing and surveillance in cystic fibrosis. Am J Respir Crit Care Med 2003;167:819-823. (Pubitemid 36801767)
13. Fairman KA. Going to the source: a guide to using surveys in health care research. J Manag Care Pharm 1999;5:150-159.
14. Fleming CM, Bowden M. Web-based surveys as an alternative to traditional mail methods. J Environ Manage 2009;90:284-292.
15. Cook C, Heath F, Thompson RA. Meta-analysis ofresponse rates in web or internet-based surveys. Educ Psychol Meas 2000; 60:821-836.